The success of copyright’s blockbuster initially sparked a boom for pharma, but recent changes present a complicated picture for shareholders. Generic versions are eating into earnings, and continued legal battles https://alexiambze715848.thezenweb.com/sildenafil-and-big-pharma-a-risky-investment-79892234